MSBHF(MSBHF)
MSBHF
No analyst ratings available
No analyst price targets available for MSBHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $20.66T | $20.75T | $21.25T | $23.25T | $23.59T |
| Low | $19.41T | $19.49T | $19.97T | $21.84T | $22.16T |
| High | $24.23T | $24.33T | $24.93T | $27.26T | $27.66T |
| EBITDA Avg | $1.16T | $1.16T | $1.19T | $1.30T | $1.32T |
| Low | $1.09T | $1.09T | $1.12T | $1.23T | $1.24T |
| High | $1.36T | $1.36T | $1.40T | $1.53T | $1.55T |
| EBIT Avg | $475.13B | $477.07B | $488.78B | $534.56B | $542.45B |
| Low | $446.45B | $448.28B | $459.28B | $502.30B | $509.71B |
| High | $557.22B | $559.50B | $573.23B | $626.92B | $636.17B |
| Net Income Avg | $1.20T | $1.19T | $1.24T | $1.32T | $1.35T |
| Low | $1.10T | $1.10T | $1.15T | $1.21T | $1.24T |
| High | $1.47T | $1.46T | $1.52T | $1.61T | $1.65T |
| EPS Avg | $313.98 | $312.37 | $326.25 | $344.95 | $353.75 |
| Low | $289.35 | $287.86 | $300.65 | $317.89 | $326.00 |
| High | $384.51 | $382.54 | $399.53 | $422.43 | $433.21 |
| Analysts (Rev / EPS) | 5 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.51T | $5.15T | $5.34T | $4.43T | $4.64T | $5.30T | $5.50T | $4.57T |
| Low | $4.51T | $5.15T | $5.34T | $4.43T | $4.64T | $5.30T | $5.50T | $4.57T |
| High | $4.51T | $5.15T | $5.34T | $4.43T | $4.64T | $5.30T | $5.50T | $4.57T |
| EBITDA Avg | $252.99B | $288.72B | $299.68B | $248.76B | $260.58B | $297.38B | $308.62B | $256.22B |
| Low | $252.99B | $288.72B | $299.68B | $248.76B | $260.58B | $297.38B | $308.62B | $256.22B |
| High | $252.99B | $288.72B | $299.68B | $248.76B | $260.58B | $297.38B | $308.62B | $256.22B |
| EBIT Avg | $103.70B | $118.35B | $122.84B | $101.97B | $106.81B | $121.90B | $126.50B | $105.03B |
| Low | $103.70B | $118.35B | $122.84B | $101.97B | $106.81B | $121.90B | $126.50B | $105.03B |
| High | $103.70B | $118.35B | $122.84B | $101.97B | $106.81B | $121.90B | $126.50B | $105.03B |
| Net Income Avg | $207.07B | $247.13B | $490.79B | $240.99B | $216.02B | $260.38B | $396.90B | $217.23B |
| Low | $207.07B | $247.13B | $490.79B | $240.99B | $216.02B | $260.38B | $396.90B | $217.23B |
| High | $207.07B | $247.13B | $490.79B | $240.99B | $216.02B | $260.38B | $396.90B | $217.23B |
| EPS Avg | $55.81 | $66.61 | $132.29 | $64.96 | $58.23 | $70.18 | $106.98 | $58.55 |
| Low | $55.81 | $66.61 | $132.29 | $64.96 | $58.23 | $70.18 | $106.98 | $58.55 |
| High | $55.81 | $66.61 | $132.29 | $64.96 | $58.23 | $70.18 | $106.98 | $58.55 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |